rs184263319
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_003954.5(MAP3K14):c.521G>A(p.Cys174Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.000645 in 1,613,668 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_003954.5 missense
Scores
Clinical Significance
Conservation
Publications
- NIK deficiencyInheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003954.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MAP3K14 | TSL:1 MANE Select | c.521G>A | p.Cys174Tyr | missense | Exon 4 of 16 | ENSP00000478552.1 | Q99558 | ||
| MAP3K14 | TSL:1 | c.521G>A | p.Cys174Tyr | missense | Exon 3 of 15 | ENSP00000482657.1 | Q99558 | ||
| MAP3K14 | c.521G>A | p.Cys174Tyr | missense | Exon 4 of 16 | ENSP00000640483.1 |
Frequencies
GnomAD3 genomes AF: 0.00124 AC: 189AN: 152190Hom.: 2 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00275 AC: 682AN: 248000 AF XY: 0.00201 show subpopulations
GnomAD4 exome AF: 0.000582 AC: 850AN: 1461360Hom.: 8 Cov.: 32 AF XY: 0.000494 AC XY: 359AN XY: 726946 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00125 AC: 191AN: 152308Hom.: 2 Cov.: 32 AF XY: 0.00142 AC XY: 106AN XY: 74480 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.